TotalMarketCap

Verrica Pharmaceuticals

VRCANasdaq United StatesHealth CareBiotechnology: Pharmaceutical Preparations

Market cap

$53.426 M

$3.11 -9.99%

Close of 6 Nov 2026

As of 6 Nov 2026, Verrica Pharmaceuticals (VRCA) has a market capitalization of $53.4M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

$35.6M

#2818 by revenue

Earnings

-$17.9M

Loss-making

Shares outstanding

17,178,786

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations, ranked by market cap

All 498 →
  1. #330RenovoRxRNXT$53.9M
  2. #331Rein TherapeuticsRNTX$53.6M
  3. #332Verrica PharmaceuticalsVRCA$53.4M
  4. #333Heron TherapeuticsHRTX$52.8M
  5. #334TalpheraTLPH$52.7M

What if Verrica Pharmaceuticals were worth as much as…

Open the what-if tool →

Gold $28.2T

$1,643,706

Per share 528,523× higher

Bitcoin $1.53T

$88,938.07

Per share 28,597× higher

Apple $5.02T

$291,975.39

Per share 93,883× higher

Or at a round number

$100.0M$200.0M$500.0M$1.00B

Where these numbers come from

Share counts and financials for Verrica Pharmaceuticals are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.